Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Original Investigation titled “Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial,”1 published online March 11, 2018, there were errors in the author byline. Instead of “The Writing Committee for the TREAT Study Group,” the author byline should read as follows: “Otavio Berwanger, MD, PhD; Jose C. Nicolau, MD, PhD; Antonio C. Carvalho, MD, PhD; Lixin Jiang, MD, PhD; Shaun G. Goodman, MD, PhD; Stephen J. Nicholls, MD, PhD; Alexander Parkhomenko, MD, PhD; Oleg Averkov, MD, PhD; Carlos Tajer, MD, PhD; Germán Malaga, MD, PhD; Jose F. K. Saraiva, MD, PhD; Francisco A. Fonseca, MD, PhD; Fábio A. De Luca, MD, PhD; Helio P. Guimaraes, MD, PhD; Pedro G. M. de Barros e Silva, MD, MHS, PhD; Lucas P. Damiani, MSc; Denise M. Paisani, PhD; Camila M. R. Lasagno, BSc; Carolina T. Candido, PharmD; Nanci Valeis, Dr; Diogo D. F. Moia, PharmD; Leopoldo S. Piegas, MD, PhD; Christopher B. Granger, MD, PhD; Harvey D. White, MD, PhD; Renato D. Lopes, MD, MHS, PhD; for the TREAT Study Group.” This article was corrected online.
Error in Author Byline. JAMA Cardiol. 2018;3(5):445. doi:10.1001/jamacardio.2018.1067
Artificial Intelligence Resource Center